DK2994146T3 - Fremgangsmåder og behandling til bestemte demyeliniserings- og dysmyeliniseringsbaserede lidelser og/eller fremme af remyelinisering - Google Patents
Fremgangsmåder og behandling til bestemte demyeliniserings- og dysmyeliniseringsbaserede lidelser og/eller fremme af remyelinisering Download PDFInfo
- Publication number
- DK2994146T3 DK2994146T3 DK14794569.5T DK14794569T DK2994146T3 DK 2994146 T3 DK2994146 T3 DK 2994146T3 DK 14794569 T DK14794569 T DK 14794569T DK 2994146 T3 DK2994146 T3 DK 2994146T3
- Authority
- DK
- Denmark
- Prior art keywords
- remyelinisation
- dysmyelinisation
- demyelinisation
- promotion
- procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361821040P | 2013-05-08 | 2013-05-08 | |
| PCT/US2014/037280 WO2014182888A2 (en) | 2013-05-08 | 2014-05-08 | Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2994146T3 true DK2994146T3 (da) | 2021-04-19 |
Family
ID=51867865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14794569.5T DK2994146T3 (da) | 2013-05-08 | 2014-05-08 | Fremgangsmåder og behandling til bestemte demyeliniserings- og dysmyeliniseringsbaserede lidelser og/eller fremme af remyelinisering |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20160143945A1 (da) |
| EP (1) | EP2994146B8 (da) |
| JP (3) | JP2016522192A (da) |
| KR (2) | KR102214256B1 (da) |
| CN (1) | CN106385796A (da) |
| AU (1) | AU2014262673B2 (da) |
| BR (1) | BR112015026805B1 (da) |
| CA (1) | CA2913205C (da) |
| DK (1) | DK2994146T3 (da) |
| ES (1) | ES2862705T3 (da) |
| HU (1) | HUE054255T2 (da) |
| IL (1) | IL242297B (da) |
| MX (1) | MX2015015467A (da) |
| PH (1) | PH12015502330B1 (da) |
| PT (1) | PT2994146T (da) |
| RU (1) | RU2686677C2 (da) |
| SG (2) | SG10201803748VA (da) |
| SI (1) | SI2994146T1 (da) |
| WO (1) | WO2014182888A2 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111821314A (zh) * | 2020-03-25 | 2020-10-27 | 巫远程 | 一种治疗近视和白内障眼药水及其制作方法 |
| CN113092401B (zh) * | 2021-03-31 | 2022-09-13 | 重庆文理学院 | 一种实验室用气敏分析系统 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7527787B2 (en) * | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| CU23229A1 (es) * | 2002-05-10 | 2007-09-26 | Ct Ingenieria Genetica Biotech | ANTAGONISTA QUIMéRICO ANTH1 |
| JP2004261885A (ja) * | 2003-02-18 | 2004-09-24 | Japan Science & Technology Agency | 有機ナノチューブへ機能性物質を導入する方法 |
| JP2007500606A (ja) * | 2003-07-28 | 2007-01-18 | ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア | ラングミュア−ブロジェットナノ構造体単層 |
| US20050202406A1 (en) * | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| US20060068026A1 (en) * | 2004-08-11 | 2006-03-30 | Hu Michael Z | Thermal electrochemical synthesis method for production of stable colloids of "naked" metal nanocrystals |
| EP1825269A4 (en) * | 2004-12-13 | 2012-06-06 | Univ South Carolina | SURFACE-REINFORCED RAMAN SPECTROSCOPY USING SHAPED GOLDNANOPARTICLE |
| US7588624B2 (en) * | 2005-03-10 | 2009-09-15 | Northwestern University | Method of producing gold nanoprisms |
| US20100092470A1 (en) * | 2008-09-22 | 2010-04-15 | Icb International, Inc. | Antibodies, analogs and uses thereof |
| DK2451284T3 (da) * | 2009-07-08 | 2017-05-01 | Clene Nanomedicine Inc | Nye guldbaserede nanokrystaller til medicinske behandlinger og elektrokemiske processer til fremstilling deraf |
| US9186371B2 (en) * | 2010-09-17 | 2015-11-17 | Japan Science And Technology Agency | Inhibitor of HMGB protein-mediated immune response activation, and screening method |
| US8969077B2 (en) * | 2010-11-05 | 2015-03-03 | The Regents Of The University Of California | Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
-
2014
- 2014-05-08 HU HUE14794569A patent/HUE054255T2/hu unknown
- 2014-05-08 RU RU2015152248A patent/RU2686677C2/ru active
- 2014-05-08 CN CN201480025754.0A patent/CN106385796A/zh active Pending
- 2014-05-08 EP EP14794569.5A patent/EP2994146B8/en active Active
- 2014-05-08 SG SG10201803748VA patent/SG10201803748VA/en unknown
- 2014-05-08 ES ES14794569T patent/ES2862705T3/es active Active
- 2014-05-08 SG SG11201508056XA patent/SG11201508056XA/en unknown
- 2014-05-08 US US14/787,812 patent/US20160143945A1/en not_active Abandoned
- 2014-05-08 MX MX2015015467A patent/MX2015015467A/es unknown
- 2014-05-08 CA CA2913205A patent/CA2913205C/en active Active
- 2014-05-08 KR KR1020157034698A patent/KR102214256B1/ko active IP Right Grant
- 2014-05-08 SI SI201431803T patent/SI2994146T1/sl unknown
- 2014-05-08 JP JP2016513064A patent/JP2016522192A/ja active Pending
- 2014-05-08 AU AU2014262673A patent/AU2014262673B2/en active Active
- 2014-05-08 WO PCT/US2014/037280 patent/WO2014182888A2/en active Application Filing
- 2014-05-08 DK DK14794569.5T patent/DK2994146T3/da active
- 2014-05-08 BR BR112015026805-6A patent/BR112015026805B1/pt active IP Right Grant
- 2014-05-08 PT PT147945695T patent/PT2994146T/pt unknown
- 2014-05-08 KR KR1020217003385A patent/KR20210018955A/ko not_active Application Discontinuation
-
2015
- 2015-10-08 PH PH12015502330A patent/PH12015502330B1/en unknown
- 2015-10-27 IL IL242297A patent/IL242297B/en active IP Right Grant
-
2018
- 2018-02-12 US US15/894,350 patent/US20180228838A1/en not_active Abandoned
-
2019
- 2019-03-06 JP JP2019041022A patent/JP6985316B2/ja active Active
-
2021
- 2021-07-01 JP JP2021109855A patent/JP2021165287A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3035926T3 (da) | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse | |
| DK3035955T3 (da) | Sammensætning og vaccine til behandling af lungekræft | |
| DK2983787T3 (da) | Fremgangsmåde til behandling af posttraumatisk stresssygdom | |
| DK3039146T3 (da) | Produkter og fremgangsmåder til behandling af amyotrofisk lateral sklerose | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3053071T3 (da) | Fremgangsmåder og processer til ikke-invasiv bedømmelse af genetiske variationer | |
| DK2943192T3 (da) | Fremgangsmåder til behandling af pancreascancer, hvilke fremgangsmåder omfatter paclitaxel og gemcitabin | |
| DK2898061T3 (da) | Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK3693158T3 (da) | Asymmetrisk forarbejdningsfremgangsmåde til krumningsreduktion i laminatstrukturer | |
| DK3685848T3 (da) | Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension | |
| DK3007695T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
| DK3076972T3 (da) | Cancerbehandling med kombination af plinabulin og taxan | |
| DK3102189T3 (da) | Sammensætning og fremgangsmåde til at fremme søvn | |
| DK3347016T3 (da) | Diagnosticering og behandling af angstlidelse | |
| DK3238707T3 (da) | Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet | |
| DK3021838T3 (da) | Behandling af fedme | |
| DK3050883T3 (da) | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter | |
| DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
| DK3508209T3 (da) | Sammensætninger med et svækket newcastle sygdoms-virus og fremgangsmåder til anvendelse til behandling af neoplasi | |
| DK3626270T3 (da) | Behandling af kardiovaskulære sygdomme | |
| DK3074544T3 (da) | Martensitholdigt rustfrit stål, stykke udført i dette stål og fremgangsmåde til fremstilling heraf | |
| DK3099800T3 (da) | Ekspression og oprensning af crm197 og beslægtede proteiner | |
| DK3033081T3 (da) | Sammensætninger og fremgangsmåder til behandling af kronisk urticaria | |
| DK3366307T3 (da) | Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri |